The Largest Pharma Company You’ve Never Heard Of Is All In On Women’s Health
Juan Camilo Arjona Ferreira | Organon Head of R&D and Chief Medical Officer
Juan Camilo Arjona Ferreira trained as a physician in Bogotá and now leads R&D at Organon, the largest pharmaceutical company dedicated to women’s health. His conviction is simple: the momentum is real, the money is ready, and no single company can move the needle alone.
The Ecosystem Approach Is the Only Approach: Women’s health is too big for any one company to solve. Juan Camilo shows up everywhere the ecosystem gathers because collaboration is the whole strategy. 🌍
The Data Gap Is Actually an Opportunity: New technology means better data at greater speed. Juan Camilo sees that as one of the most exciting openings in women’s health right now. 📊
The Money Is on the Sidelines: Governments, venture capital, family offices. The funding landscape looks completely different than it did five years ago. 💰
A Name Change That Changes Everything: PCOS was recently renamed to better reflect what the condition actually is. Juan Camilo breaks down why that matters for the 13% of women worldwide affected by it. 🔬
Everything Is Possible: Don’t limit yourself to what you think is possible. Say yes. Stay curious. That's his advice in a nutshell! 🌱
